(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CATALYST HEALTH RX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CATALYST HEALTH RX

ST13

US500000090461377

Class

35, 39

Filing

90461377

Registration

7089194

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

06/27/2023

Trademark type

Word

Nice classes

35, 39

Filing date

01/12/2021

Registration date

06/27/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/27/2023

Last transaction

06/27/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/08/2019

First use in commerce

01/08/2019

Drawing code

4

Owner type

16

Owner location

PLANO, TX, US

Examiner

MANGUBAT, ALEXANDER GEORGE

Law office

N30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CATALYST HEALTH GROUP HOLDINGS, LLC
Stratifi Health Holdings, LLC

Representatives

Carol M. Wilhelm GRAY REED & MCGRAW LLP

Technical classification

Nice Classes

Class 35Class 39

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail pharmacy services; Pharmaceutical servicesprocessing online and telephone prescription orders in retail and central fill pharmacies

Class 39

Pharmacy packaging service that alignssorts and packages a patient's medications by date and time into individual packets

Publications

History of USPTO decisions and trademark events.

25 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/27/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

06/27/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/11/2023

PUBO

PUBLISHED FOR OPPOSITION

04/11/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/22/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/03/2023

DOCK

ASSIGNED TO EXAMINER

03/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/13/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/13/2023

ALIE

ASSIGNED TO LIE

01/13/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/16/2022

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

08/30/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/08/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/28/2022

GNSL

LETTER OF SUSPENSION E-MAILED

02/28/2022

CNSL

SUSPENSION LETTER WRITTEN

02/28/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/31/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/31/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/31/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/03/2021

GNRT

NON-FINAL ACTION E-MAILED

08/03/2021

CNRT

NON-FINAL ACTION WRITTEN

08/03/2021

DOCK

ASSIGNED TO EXAMINER

07/21/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/12/2021

NWAP

NEW APPLICATION ENTERED

01/15/2021

Continuous trademark protection

Get notified about every new filing that threatens CATALYST HEALTH RX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.